The world needs better vaccines. We’re striving to create them. A novel approach centered around virus-like particles (VLPs) We’re a clinical-stage company working to develop a new kind of vaccine that can protect vulnerable older adults from multiple respiratory viruses. Underpinning this work is a unique approach that utilizes virus-like particles (VLPs). Our VLPs are […]...